Hedge Fund Hits Another Horizon Patent With AIA Review Bid

Hedge fund manager Kyle Bass continued his attack on patents belonging to some of the world's biggest drug companies Friday, filing a petition challenging the validity of a second patent on...

Already a subscriber? Click here to view full article